Exclusive: Sanofi tapped ScionxBio to screen its mRNA candidates, the startup’s first deal since splitting from Eleven Therapeutics.
endpoints.newsExclusive: Sanofi taps new startup ScionxBio for long-acting RNAScionxBio signs first deal with Sanofi to screen mRNA candidates via its TERA platform. CEO Adi Gilboa-Geffen declined to share financial details.
0 reposts0 likes